Clinical trial
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters…
NCT00037050 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00037050 |
|---|---|
| Title | Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria |
| Official title | Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram-Positive Bloodstream Infections |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bacterial Infections, Gram-Positive Bacterial Infections, Bacteremia |
| Intervention type | Drug |
| Interventions | Linezolid, Vancomycin, Oxacillin, Dicloxacillin |
| Enrollment | 739 |
| Start date | Apr 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | May 15, 2002 |
| Last update posted | Sep 14, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: